REWahoo
Give me a museum and I'll fill it. (Picasso) Give
We've all heard the reports about the clinical testing involving chloroquine and Remdesivir as treatments for Covid-19. Here is a new one under study:
Head lice drug emerges as potential coronavirus treatment, studies show
Head lice drug emerges as potential coronavirus treatment, studies show
The latest surprising lead for researchers is an antiparasitic drug called ivermectin, sometimes used to treat head lice.
Research into the drug’s viability in treating COVID-19 is still in its early stages – far too soon to call it a breakthrough. But with the emergence of two preliminary studies yielding promising results, experts are expressing cautious optimism.
“We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours there was a really significant reduction in it,” said Dr. Kylie Wagstaff, the leader of the team from Melbourne’s Monash Biomedicine Discovery Institute.
The coronavirus is not a parasite, but experts suggest that the drug essentially treats it like one and blocks the viral RNA from invading healthy cells. Unable to enter the cell, the RNA is slowed from replicating, giving the patient's immune system more time to fight it off.
The Monash study took place at the cellular level, or in vitro. The next step, authors note, is “to determine the correct human dosage – ensuring the doses shown to effectively treat the virus in vitro are safe for humans.”